Max Planck Society (Max-Planck-Gesellschaft), Germany’s leading basic research organization, has announced that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify a…
Month: September 2011
Trial of Rituximab for Graves’ Ophthalmopathy
Status: Recruiting,
Condition Summary: Thyroid-associated Ophthalmopathy
Advanced Bionics Announces FDA Approval For U.S. Market Re-Entry Of The HiRes 90K Cochlear Implant
Advanced Bionics (AB), the only U.S.-based manufacturer of cochlear implants and a subsidiary of Switzerland-based Sonova, announced today the approval of the FDA for immediate market re-entry of the HiRes 90K cochlear implant in the United States…
Venus Williams withdraws from US Open due to Sjogren syndrome
Sjogren syndrome was in the news recently when tennis player, Venus Williams, was forced to withdraw form the US Open tennis tournament due to symptoms from the disease.
Proton Irradiation for Choroidal Melanomas Near Optic Nerve
For patients with melanoma near the optic nerve, proton beam radiotherapy offers benefits in terms of eye conservation and low recurrence, but with a tradeoff in visual acuity, according to a new study. Reuters Health Information
New collaboration reinforces Sanofi’s translational discovery platform for retinal diseases
The Max Planck Society (Max-Planck-Gesellschaft), Germany’s leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to iden…
CHAM experts available to discuss variety of back-to-school issues
Experts from The Children’s Hospital at Montefiore (CHAM) are available for interviews on a variety of back-to-school issues.
Common Treatments Can Lead To Antibiotic Resistance
Overexposure to antibiotics has long been a concern in the medical community most specifically the development of antibiotic resistant infections as a result of repeated use…
Eyelid Lipid Plaques Predict CV Disease (CME/CE)
(MedPage Today) — The presence of the lipid-containing yellow plaques known as xanthelasmata on the eyelids is an independent predictor of cardiovascular disease, a large prospective study found.
EHR Voice Recognition: An End to the ‘No Eye Contact’ Problem?
Physicians often complain that when using an EHR, they’re so busy typing that it’s hard to make good eye contact with patients. New voice recognition software holds promise, but is it there yet? Medscape Business of Medicine
Orphan Drug Status for Corneal Cross-Linking in Keratoconus
Corneal cross-linking is the first medical therapy available in the US to slow disease progress. Medscape Medical News
Visual Cortex Brain Cell Maturity Depends On Experience With Light
An investigation team in MIT’s Picower Institute for Learning and Memory and the Department of Brian and Cognitive Sciences, have identified tiny molecular signals that administer how the connections between brain cells mature when they eyes first see …
Repeat Antibiotic Injections in Eyes Breed Resistance (CME/CE)
(MedPage Today) — Bacterial flora in eyes that were treated routinely with ophthalmic antibiotics to suppress infection after intravitreal drug injections frequently became resistant to multiple antibiotics, researchers said.
A Baby With Droopy Eyelids
What condition do you suspect is present in this 16-month-old girl with droopy eyelids and a chin-up head position? Medscape Ophthalmology
Lucentis receives Health Canada approval to treat vision loss from DME
Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from diabetic macular edema, one of the major causes of adult vision loss and an important complication of the growing epidemic of diabetes.
BVES protein may play a role in colon cancer progression
A protein critical in heart development may also play a part in colon cancer progression. Research led by investigators from Vanderbilt-Ingram Cancer Center and the Vanderbilt Eye Institute suggests that the protein BVES (blood vessel endocardial subst…
Bausch + Lomb to launch VICTUS Femtosecond Laser Platform for cataract surgery
Bausch + Lomb, the global leader in eye health, and Technolas Perfect Vision GmbH (TPV), a leading ophthalmology laser company, plan to introduce the VICTUS Femtosecond Laser Platform at the upcoming XXIX Congress of the European Society of Cataract an…
Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction
Status: Not yet recruiting,
Condition Summary: Graves Ophthalmopathy
Chemo, Radiation Raise Complications in Anophthalmic Sockets
Combined therapy for retinoblastoma aimed at saving a child’s affected eye increases the likelihood of long-term complications if enucleation becomes necessary, according to findings published in the August 18th online issue of Ophthalmology. Reuters…
VIP-200 Pupillometer Is a New Portable Device to Measure Pupils for Refractive Surgery
Neuroptics Inc. from Irvine, California released the VIP-200 Pupillometer, a hand-held device to screen patients for refractive surgery. The device helps eye surgeons to optimize patients for a laser-assisted in situ keratomileusis (LASIK) procedures and fitting of multifocal intraocular lenses (IOLs). The Pupillometer can simulate scotopic, low (Read more...)